{"name":"Krystal Biotech, Inc.","slug":"krystal-biotech-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":389130000,"revenueGrowth":33.9,"grossMargin":0,"rdSpend":58045000,"netIncome":204831000,"cash":496304000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"KB105","genericName":"KB105","slug":"kb105","indication":"Other","status":"phase_2"},{"name":"Topical Beremagene Geperpavec","genericName":"Topical Beremagene Geperpavec","slug":"topical-beremagene-geperpavec","indication":"Dystrophic epidermolysis bullosa","status":"phase_3"},{"name":"KB301","genericName":"KB301","slug":"kb301","indication":"Other","status":"phase_1"},{"name":"KB803","genericName":"KB803","slug":"kb803","indication":"Recessive dystrophic epidermolysis bullosa (RDEB)","status":"phase_3"}]}],"pipeline":[{"name":"KB105","genericName":"KB105","slug":"kb105","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Topical Beremagene Geperpavec","genericName":"Topical Beremagene Geperpavec","slug":"topical-beremagene-geperpavec","phase":"phase_3","mechanism":"Beremagene geperpavec is a gene therapy that uses a viral vector to deliver a gene to the skin, which then produces a protein to treat the condition.","indications":["Dystrophic epidermolysis bullosa"],"catalyst":""},{"name":"KB301","genericName":"KB301","slug":"kb301","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"KB803","genericName":"KB803","slug":"kb803","phase":"phase_3","mechanism":"KB803 is a gene therapy that delivers a functional COL7A1 gene to restore type VII collagen production in patients with recessive dystrophic epidermolysis bullosa.","indications":["Recessive dystrophic epidermolysis bullosa (RDEB)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNZng1WlVHNlJXZWJHZnlKUXM0VE52LXJoVFQ1Z3hXWGhxWXNUYmNLeW1rTmcxY3VGRzBpTXBfTDFIN1FLQmxyWXVQaVptUTN5eDJnXzFSc1YwWC1ObFBON25OOUpHWmpPUjU3aWFfaHhiV2hHdFQwTnRUVkhqY0hwTG5ONUcxWE50RWtmc1dFbDh5bHJxN1E?oc=5","date":"2026-02-16","type":"deal","source":"The Motley Fool","summary":"Got $300? 2 Biotech Stocks to Buy and Hold Forever - The Motley Fool","headline":"Got $300? 2 Biotech Stocks to Buy and Hold Forever","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPb20zcjRFS0hGV0U3cFE5T1BNb0tjeHVpMnBKNTh2NU9lUF9OZkl0UW1CXzRWWWR6cHUzcHEyLVlxMDY4R0F4VFBaRmNiaHBIUV8yT0JnTmxoYWNEMUllWEF3enlreGU1MTRfRVNCQUlpdl8yZC1nbHc3SWtWdU9XVlYyNkVGRzFuWThR?oc=5","date":"2026-02-11","type":"pipeline","source":"Mugglehead Magazine","summary":"Krystal Biotech co-founder makes Forbes 250 innovators list - Mugglehead Magazine","headline":"Krystal Biotech co-founder makes Forbes 250 innovators list","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQdnFRbVl4TTZndXFtQmVjd3Z5N2NEUnZPR2NxTkQ1cElyMTBEWXN4VWlKanNwUk1uXzVTR2VPbkZyWl9ralcyVGN6VzlFV1JxaHJoRk4xSDl1el9hbEMwRlRxOV82Q2g4MHdzOEhpWXlRcm9WbDVMYzdNUzFNZmJzT0RyYUVoVGZfSDliZV9rNGIzWl9xXzZNbE5ja3ExUQ?oc=5","date":"2026-01-29","type":"regulatory","source":"Finviz","summary":"Biogen's Autoimmune Disease Candidate Gets FDA's Breakthrough Status - Finviz","headline":"Biogen's Autoimmune Disease Candidate Gets FDA's Breakthrough Status","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNeXd3c2VxdkoyUVZWbXkzaEZpb0N6SFV2aU5fNUhHQjBJWTRIRFluNGRoVWI5a2Y4eDdGZ1Y2WmdQU0tqeW9ZektoVi1MTlRLcGVMQng1SFc0Zmt1ZE9VUFJ5RUVfSi1FUHI1M0hlX1JIV1M4Q1RyOTlYMU92ZDVnNUt3?oc=5","date":"2026-01-19","type":"pipeline","source":"Yahoo Finance","summary":"What Does Wall Street Think About Krystal Biotech (KRYS)? - Yahoo Finance","headline":"What Does Wall Street Think About Krystal Biotech (KRYS)?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOZHlWWWlOdzAyODhjWWtPSjFDYUdWSERfNlMxemNheF8xNVFXamRVZHdvQV9DUktHeUExOG9GVHNJQ1dOZ2gtWDFRV0x6eG83VFdiOEljNzhob21RUnhYUHFtUTlmWGpPUC0zMkNUY0hhUGk1N3ZtWmdkbWRqYVp6OFlBNUJScW42dmdIRTZJME45NmVsOWpR?oc=5","date":"2026-01-15","type":"pipeline","source":"Finviz","summary":"Apellis Stock Crashes 23% in a Week: Here's What You Should Know - Finviz","headline":"Apellis Stock Crashes 23% in a Week: Here's What You Should Know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNbWZEbEx2djVDMkxOYVpWalczT2FDQnU5eGY5WlhMZEVXRjVpX0ZOYkZkLXJqT2Q3X0Vna0kyQlFUMFdVOFlMRmpEemd1X29iVUJ6WGI5YTlvRzJDZ2VRbmJ4OG0zbkpVc1NITG1ZZ3JBY1A3c2FiWHdUaGgxS3I2b1FVWVdNTkZka3c?oc=5","date":"2025-12-23","type":"pipeline","source":"Fierce Biotech","summary":"The top 5 stock picks for biotech in 2026: William Blair - Fierce Biotech","headline":"The top 5 stock picks for biotech in 2026: William Blair","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQNGl0YkViMjVPOHJvOFZTQWUyQThGLTdsckhOaXB1MmVpbENkVXppVUxtZHZuUUNhSmlzYVBSc2VTQ0VzWDNVa0FLRGhxc0ZBNklndENNMi04TEJEUWdRa1NOSWZWMXlJbE8teTlYd3drMFNrNmp2OXBCNnptUlEyMkJrM3praVZ1bm92TzFKWnhjeWxZTWl6TnFOb0VCanJGeWxsZkpYWQ?oc=5","date":"2025-11-16","type":"pipeline","source":"Seeking Alpha","summary":"Krystal Biotech: VYJUVEK Gene Therapy Well Positioned For Growth (NASDAQ:KRYS) - Seeking Alpha","headline":"Krystal Biotech: VYJUVEK Gene Therapy Well Positioned For Growth (NASDAQ:KRYS)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-09","type":"earnings","source":"simplywall.st","summary":"Market Participants Recognise Krystal Biotech, Inc.'s (NASDAQ:KRYS) Earnings Pushing Shares 29% Higher - simplywall.st","headline":"Market Participants Recognise Krystal Biotech, Inc.'s (NASDAQ:KRYS) Earnings Pushing Shares 29% Higher","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPYWF1OGMwRFNPTm1NQUIwLXZNazhmOUxnOWNBVVU1QmV1THQwQjVKOUZjV2dPSWJvNkhKY1YxeHNMSXo1Z2JfdjZtdU91TkVPV0RXcy1YcU92Q0ZpRUlGemFkX3FBUjlPdlBtTTNfWmZWTHZkRlNuSVVJOUdLWEQ5QzdGNlJRakRJUXFiQUpZbGh1MXlCVENpU2VGZE5xYkU?oc=5","date":"2025-05-14","type":"pipeline","source":"MarketBeat","summary":"Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore - MarketBeat","headline":"Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPVFhVOE1McTVhWGgyUGdCMkVoQWtJVThHY21ablQyWVFBdWdDaXplMFByMWQ2R0dkcExIUzg3NGJRQm50cEdSOTBQQVV5Ui1CN1JHRWUzMVBzd202WDZ1ak1vSlV0RldXQzRrR1NiSGx5WFppUWFHejFvYUh5cWdlcFFta1dqSE5Cd1E?oc=5","date":"2024-11-07","type":"pipeline","source":"Labiotech.eu","summary":"Cystic fibrosis: Five biotechs breathing life into the therapeutic space - Labiotech.eu","headline":"Cystic fibrosis: Five biotechs breathing life into the therapeutic space","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOOTFWcDVoVDdkWlN2c096eUJSQ0hoN1Q5cG5rN1dVM3VwTy0zZTAtVWo3dTBUOXY0SWdJX2JVZWRGaV90QmNmX1RoRnBBMzhLN0lYcGV5NERRRmZnWVIyY1hPZXJ3SmJPMjJTTWNvc2h1QnZhS0lKWFVaWmJqQUlIeTdPSkNwUkVuLUlyalNnSXRaOHVXOTgyaEFUeDdPWFVhSHNYMVdIUDE4SU9YTU9UaUV2dmxNUHBSc2N6VVUyUnJLQQ?oc=5","date":"2023-05-19","type":"regulatory","source":"Krystal Biotech, Inc","summary":"Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa - Krystal Biotech, Inc","headline":"Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) f","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNNm1aM09rSWdTam1yQjZmeGZScW9PYVhCREN4SzBXLWhoSU5EQmJyeXdUYlBESzNpVkZfQUlEU0p0SFNKLTZjVmpJT2FKbC1lVnZRNjZiemwxbGZnZW53TEdwM2pWdUZUS29KRm9UeUE3d2JCRGxIUkNvMzhfWVBxd2JKcktMSVhvYzI1TXd2cWU0T0ZwdHUzT3VyNHZTWVpyUlJMeTMzeTY2a0EtaFRTblhBbVZJcU9OU0dkSGl1MFZ2bHQ0MGd4ZmNxVQ?oc=5","date":"2023-05-19","type":"regulatory","source":"Reuters","summary":"U.S. FDA approves Krystal Biotech's skin-disorder gene therapy - Reuters","headline":"U.S. FDA approves Krystal Biotech's skin-disorder gene therapy","sentiment":"positive"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_2":1,"phase_3":2,"phase_1":1},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":389130000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":389130000,"period":"2025-12-31"},{"value":290515000,"period":"2024-12-31"},{"value":50699000,"period":"2023-12-31"},{"value":0,"period":"2022-12-31"},{"value":0,"period":"2021-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":58045000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":204831000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":496304000,"cashHistory":[],"totalAssets":1333794000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}